Blood-less Medicine in Gynecologyand Oncogynecology

1. Aubron, C., Bailey, M., McQuilten, Z., et al. Duration of red blood cells storage and outcome in critically ill patients. J crit Care, 2014, 29(3), p. 476–e1.

2. Afshari, A., Wikkelso, A., Brok, J., et al. Thrombelastography (TEG) or thromboelastometry (ROTEM) to monitor haemotherapy versus usual care in patients with massive transfusion. Cochrane Database Syst Rev 2011; 3:CD007871.

3. Balogh, Z., Jones, F., D‘Amours, S., et al. Continuous intra-abdominal pressure measurement technique. Am J Surg, 2004, 188, 6, p. 679–684.

4. Blombäck, B. Fibrinogen and fibrin-proteins with complex roles in hemostasis and thrombosis. Clin Hemorheol Microcirculation, 1996, 16(4), p. 383–477.

5. Capasso, A., Pisano, A. Leukocyte depletion of transfused blood to reduce perioperative mortality. In Reducing mortality in the perioperative perio. Springer International Publishing, 2014, p. 85–92.

6. Carson, JL., Noveck, H., Berlin, JA., Gould, SA. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion, 2002, 42, 7, p. 812–818.

7. Celebi, N., Celebioglu, B., Selcuk, M., et al. The role of antifibrinolytic agents in gynecologic cancer surgery. Saudi Med J, 2006, 27, p. 637–641.

8. Čundrle, I., Vlach, O., Zimová, I., et al. Eficience jednotlivých metod bezkrevní medicíny. Novinky v anesteziologii, intenzivní medicíně a léčbě bolesti. 2008, s. 124–126.

9. De Aloysio, D., Altieri, P., Pretolani, G., et al. The combined effect of a GnRH analog in premenopause plus postmenopausal estrogen deficiency for the treatment of uterine leiomyomas in perimenopausal women. Gynecol Obstet Invest, 1995, 39, 2, p. 115–119.

10. Dodd, RY. Current safety of the blood supply in the United States. Int J Hematol, 2004, 80, 4, p. 301–305.

11. Ducloy-Bouthors, AS., Jude, B., Duhamel, A., et al. High-dose tranexamic acid reduces blood loss in postpartum haemor-rhage. Crit Care, 2011, 15, R117.

12. Fenger-Eriksen, C., Lindberg-Larsen, M., Christensen, AQ., et al. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Brit J Anaesth, 2008, 101(6), p. 769–773.

13. Frati, A., Ducarme, G., Wernet, A., et al. Uterine artery embolization as treatment for life-threatening haemorrhage from a cervical choriocarcinoma: A case report. Eur J Obstet Gynec Reprod Biol, 2008, 141(1), p. 87–88.

14. Glance, LG., Dick, AW., Mukamel, DB., et al. Association bet-ween intraoperative blood transfusion and mortality and morbidity in patients undergoing noncardiac surgery. Anesthesiology, 2011, 114, p. 283–292.

15. Goodnough, LT., Shander, A. Patient blood management. Anesthesiology, 2012, 116(6), p. 1367–1376.

16. Gostout, BS., Cliby, WA., Podratz, KC. Prevention and management of acute intraoperative bleeding. Clin Obstet Gynecol, 2002, 45, 2, p. 481–491.

17. Harrison, WJ. Early complications of abdominal and vaginal hysterectomy. Obstet Gynecol Surv, 1995, 50, 11, p. 795–805.

18. Hébert, PC., Wells, G., Blajchman, MA., et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. N Engl J Med, 1999, 340(6), p. 409–417.

19. Howard, RJ., Straughn, JM., Huh, WK., Rouse, DJ. Pelvic umbrella pack for refractory obstetric hemorrhage secondary to posterior uterine rupture. Obstet Gynecol, 2002, 100, 5,p. 1061–1063.

20. Kozek-Langenecker, SA., Afshari, A., Albaladejo, P., Santullano, CAA., et al. Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology. Eur J Anaesth (EJA), 2013, 30(6), p. 270–382.

21. Linden, JV., Paul, B., Dressler, KP. A report of 104 transfusion errors in New York State. Transfusion, 1992, 32, 7, p. 601–606.

22. Little Jr, DM. „Controlled Hypotension“ in anesthesia and surgery. Anest Analgesia, 1956, 35(4), 284.

23. Longmore, JM. Oxford handbook of clinical medicine. 8. vyd. Oxford : Oxford university press, 2010. ISBN 9780199232178.

24. Martinowitz, U., Michaelson, M. Israeli Multidisciplinary rFVIIa Task Force Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force. J Thromb Haemost, 2005, 3, p. 640–648.

25. Nicholls, MD. Transfusion: morbidity and mortality. Anaesth Intensive Care, 1993, 21, 1, s. 15–9.

26. Nuttall, GA., Horlocker, TT., Santrach, PJ., et al. Predictors of blood transfusions in spinal instrumentation and fusion surgery. Spine, 2000, 25(5), p. 596–601.

27. Rajagopalan, S., Mascha, E., Na, J., Sessler, DI. The effects of mild perioperative hypothermia on blood loss and transfusion requirement. Anesthesiology, 2008, 108(1), p. 71–77.

28. Rahe-Meyer, N., Pichlmaier, M., Haverich, A., et al. Bleeding management with fibrinogen concentrate targeting a high-normal plasma fibrinogen level: a pilot study. Br J Anaesth, 2009, 102, p. 785–792.

29. Rayburn, WF., et al. Prevention and management of complications from gynecologic surgery. Obstet Gynec Clinics, 2010, 37, 3, p. 427–436.

30. Santoso, JT., Saunders, BA., Grosshart, K. Massive blood loss and transfusion in obstetrics and gynecology. Obstet Gynecol Surv, 2005, 60, 12, p. 827–837.

31. Santoso, JT., Lin, DW., Miller, DS. Transfusion medicine in obstetrics and gynecology. Obstet Gynecol Surv, 1995, 50, 6, p. 470–481.

32. Schonauer, C., Tessitore, E., Barbagallo, G., et al. The use of local agents: bone wax, gelatin, collagen, oxidized cellulose. Eur Spine J, 2004, 13(1), p. S89–S96.

33. Sesti, F., Ticconi, C., Bonifacio, S., Piccione, E. Preoperative administration of recombinant human erythropoietin in patients undergoing gynecologic surgery. Gynecol Obstet Invest, 2002, 54, 1, p. 1–5.

34. Shakur, H., Roberts, I., et al., CRASH-trial collaborators. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant hae-morrhage (CRASH-2): randomised, placebo-controlled trial. Lancet, 2010, 376, p. 23–32.

35. Shander, A., Van Aken, H., Colomina, MJ., et al. Patientblood management in Europe. Brit J Anaesth, 2012, 139.

36. Shander, A., Javidroozi, M., Perelman, S., et al. From bloodless surgery to patient blood management. Mount Sinai J Med: J Translat Personalized Med, 2012, 79(1), p. 56–65.

37. Simou, M., Thomakos, N., Zagouri, F., et al. Non-blood medical care in gynecologic oncology: a review and update of blood conservation management schemes. World J Surg Oncol, 2011, 9, p. 142.

38. Slipac, J. Bezkrevní medicína. Praha: Triton, 2008.

39. Smith, DC., Wyatt, JF. Embolization of the hypogastric arteries in the control of massive vaginal hemorrhage. Obstet Gynec Survey, 1977, 32(7), p. 490–494.

40. Spahn, DR., Cerny, V., Coats, TJ.,et al., Task Force for Advanced Bleeding Care in Trauma. Management of bleeding following major trauma: a European guideline. Crit Care, 2012, 11(1), R17.

41. Spinella, PC., et al. Duration of red blood cell storage is associated with increased incidence of deep vein thrombosis and in-hospital mortality in patients with traumatic injuries. Critical Care, 2009, 13:R151 doi:10.1186/cc8050,

42. Tamizian, O., Arulkumaran, S. The surgical management of postpartum haemorrhage. Curr Opin Obstet Gynecol, 2001,13, 2, p. 127–131.

43. Tinmouth, A., Fergusson, D., Yee, IC., Hebert, PC. Clinical consequences of red cell storage in the critically ill. Transfusion, 2006, 46(11), p. 2014–2027.

44. Tomizawa, Y. Clinical benefits and risk analysis of topical hemostats: a review. J Artific Organs, 2005, 8(3), p. 137–142.

45. Weber, CF., Görlinger, K., Meininger, D., et al. Point-of-care testing: a prospective, randomized clinical trial of efficacy in coagulopathic cardiac surgery patients. Anesthesiology, 2012, 117(3), p. 531–547.

46. Williams-Johnson, JA., McDonald, AH., Strachan, GG., Williams, EW. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. West Indian Med J, 2010, 59(6), p. 612–624.

47. Wurnig, C., Schatz, K., Noske, H., et al. Subcutaneous low-dose epoetin beta for the avoidance of transfusion in patients scheduled for elective surgery not eligible for autologous blood donation. Eur Surg Res, 2001, 33, 5–6, p. 303–310.

48. Yamashita, Y., Harada, M., Yamamoto, H., et al. Trans-catheter arterial embolization of obstetric and gynaecological bleeding: efficacy and clinical outcome. Brit J Radiol, 1994, 67(798), p. 530–534.